A股異動 | 星網宇達(002829.SZ)放量漲停 機構指新興業務實現高速增長
格隆匯2月13日丨星網宇達(002829.SZ)早盤放量漲停,錄得兩連板。現報28.8元,成交量放大至3.39億元,最新總市值45.2億元。

國海證券研報指,2019年,公司雖然收入佔比較大的海工裝備業務大幅下滑下,但光電雷達探測、衞星通信等新興業務實現高速增長,支撐了公司的發展,新興業務已經成為公司增長的重要引擎。並且公司無人系統快速推進,訂單有望陸續落地。首次覆蓋,給予買入評級。
近期無人機成抗擊疫情利器,多重優勢帶來巨大市場空間。到2025年,民用無人機產值將達到1800億元,年均增速25%以上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.